fbpx Skip to main content

In this MD Newsline exclusive interview with Dr. Alecia Nero, hematologist and associate professor in internal medicine and pediatrics at UT Southwestern Medical Center,  we discuss how treatment has improved for sickle cell disease in recent years. 

Dr. Nero is the Director of UT Southwestern’s Transition Sickle Cell Program and Adult Sickle Cell Program. UT Southwestern is part of the Sickle Cell Disease Clinical Trials Network. 

MD Newsline:

How has treatment improved for sickle cell disease in recent years?


Dr. Alecia Nero:

“There are limited treatments for patients with sickle cell disease. However, there have been more drug approvals recently. In my opinion, there were a few too many. However, any advancements in treating sickle cell disease are better than nothing. I’m glad we’re making progress in the field, and there’s greater awareness of sickle cell disease because of some of these newer therapies. So, I think we’re starting to move in the right direction.”

Responses have been condensed and lightly edited.

Share this article
You May Also Like::  FDA Approves Oxbryta, Second Sickle Cell Drug Approval in 10 Days